Skip Navigation
Johns Hopkins Bloomberg School of Public Health
Bookmark and Share
VIEW-hub is a publicly accessible, interactive platform that enables users to visualize real-time information on vaccine use, product type, coverage levels, and impact assessments. More
India becomes the first country in South or Southeast Asia to introduce an indigenous rotavirus vaccine--ROTAVAC®--into the Universal Immunization Programme, starting with four states.
In a new Health Affairs study covering 94 low- and middle-income countries, IVAC's Sachiko Ozawa found that immunization will yield more than $586 billion in economic benefits in the Decade of Vaccines (2011-2020). More
A new PCV impact study in The Gambia found the vaccine reduced invasive pneumococcal disease (IPD) by more than half, demonstrating that low- and middle-income countries that introduce PCV13 can expect substantial reductions in IPD. More
The ROTA Council has released a new white paper detailing the latest evidence on rotavirus and key interventions and recommendations to prevent rotavirus illnesses and deaths More
A new Lancet Global Health study by IVAC’s Dr. Laura Hammitt shows a reduction in invasive Hib disease without a booster dose in Kilifi, Kenya. More

Featured IVAC Publications

Rotavirus: Common, Severe, Devastating, Preventable

Return on Investment from Child Immunization in Low- and Middle-Income Countries, 2011-20

Effect of Hib vaccination without a booster dose on invasive Hib disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya

Basket Funds: A Pooled Arrangement to Finance Primary Health Care Delivery and Address the Funding Flow in Nigeria

2015 Pneumonia and Diarrhea Progress Report

Coverage, Cost, and Safety Impacts of Primary Container Choice

Costing Dengue Cases And Outbreaks: A Guide to Current Practices and Procedures

White Paper: Landscape Analysis of Routine Immunization in Nigeria

Global Vaccine Introduction Status

IVAC has launched a new, interactive platform that enables users to instantly visualize real-time information on vaccine use, product type, coverage, and impact assessments.

VIEW-hub - Now live!

Learn more about the VIEW-hub platform

Download the May 2016 VIEW-hub report

Advocacy for Immunisation Online Tool

A platform, jointly developed by PATH and IVAC, designed to help vaccine champions advocate for improved immunisation systems and access to vaccines.

Check out the tools, resources, guidelines, and more!

Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants: A Landscape Analysis of Evidence Supporting Different Schedules - Supplement in The Pediatric Infectious Disease Journal

The most comprehensive review of dosing schedules for PCV in various populations across time was published in the January 2014 issue of the PIDJ. To access this supplement, please click here.

Hib Initiative Supplement in Journal of Pediatrics

In a special supplement sponsored by the Hib Initiative, more than 115 authors contribute to the evidence for Hib vaccines in developing countries. It includes articles on vaccine impact, disease surveillance, cost-effectiveness, morbidity, and other key topics. To read this important supplement, please click here.

Connect With Us

Subscribe to the IVAC newsletter, Focus on Vaccine Access:

Latest Updates

Gaps in Vaccine Coverage Highlighted With New Report and Online Tool


Good immunization data is not just for experts and nerds, it is for us all

IVAC Launches VIEW-hub Interactive Vaccine Data Visualization Platform

Recent Publications Highlight the Costs of Pneumococcal Disease and Impact of Vaccines in The Gambia

WHO Recommends Dengvaxia® Use in Areas of High Dengue Risk

IVAC Joins Newly Launched Dose Per Container Partnership (DPCP) Led by JSI

WHO Launches a New Vaccine Pipeline Tracker

The Potential Economic Impact of the Zika Virus

Rwanda Study Demonstrates the Benefits of Routine Vaccination Against Rotavirus in Low-Income Settings

Thailand Study Uncovers the High Burden of Pneumococcal Pneumonia in Adults

Anita Shet, MD, PhD, Joins IVAC as Pediatric Infectious Disease Specialist and Epidemiologist

Statement by the Dengue Vaccine Initiative on Mexico’s Regulatory Approval of Sanofi Pasteur’s Dengue Vaccine, Dengvaxia®

We're Not Winning This Fight

Diarrheal Disease: The Unfinished Agenda

Pakistan’s Doctors, Researchers and Teachers Unite Against One Disease

New Report Highlights Gains in Child Survival, But there's Still Work to be done to Address Leading Killers

Read more News from IVAC →